Radioembolization and chemoembolization with drug-eluting microspheres for the treatment of liver tumors
Secco A, Augustovski F , Pichon-Riviere A, , García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L
Record ID 32016000916
Spanish
Authors' recommendations:
Low-quality evidence does not allow to conclude if radioembolization and chemoembolization with drug-eluting microspheres are worse, similar or better than other standard treatments for primary or metastatic liver tumor. Most international clinical practice guidelines agree that the evidence is not enough, although sometimes they consider its potential use as an additional alternative (specially radioembolization with drug-eluting microspheres) in very special cases of irresecable tumors. Coverage policies of the US private sponsors consulted consider radioembolization with drug-eluting microspheres for specific cases of irresecable tumors and they consider chemoembolization with drug-eluting microspheres as experimental.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Humans
- Embolization, Therapeutic
- Liver Neoplasms
- Microspheres
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.